Work Here?
Overview
Phoenix offers telemedicine-based men’s health care in Canada by connecting men with licensed Canadian physicians for online consultations and treatment, including erectile dysfunction and weight loss. The process uses an online intake and virtual visit, after which a physician may prescribe medications that are shipped free of charge; the company does not manufacture drugs or run a pharmacy. It differentiates itself by focusing on men’s health, employing Canadian-licensed doctors, providing discreet at-home care, and offering ongoing physician support within a Canadian framework. Its goal is to improve access to personalized, convenient, and confidential men’s health care in Canada through telehealth and continuous professional guidance.
About Phoenix
Industries
Consumer Software
Healthcare
Company Size
51-200
Company Stage
Debt Financing
Total Funding
$37M
Headquarters
Toronto, Canada
Founded
2020
Get referred to Phoenix
See people who can refer or advise you
Simplify's Take
What believers are saying
- Thousands joined the semaglutide waitlist before the May 2026 launch.
- Phoenix’s July 17, 2026 site shows expansion into labs, testosterone, skincare, smoking cessation.
- Canada-wide free discreet shipping and online provider access lower friction versus clinics.
What critics are saying
- Health Canada scrutiny hit Phoenix ads in The Globe and Mail on February 13, 2026.
- Generic semaglutide commoditizes Phoenix’s core weight-loss offering and pressures margins immediately.
- Dependent pharmacy partners and prescribers create an existential regulatory shutdown risk.
What makes Phoenix unique
- Phoenix built a men’s-health telehealth brand around ED, hair loss, and weight management.
- Phoenix and Raven launched generic semaglutide nationwide on May 21, 2026.
- Trulioo verified Phoenix patients on April 14, 2026, strengthening regulated onboarding.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$37M
Above
Industry Average
Funded Over
4 Rounds
Y CombinatorIndustry standards
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↑ 6%2 year growth
↑ 5%Phoenix and Raven, Canadian digital health providers, have become the first telehealth platforms in the country to offer generic semaglutide directly to patients, with orders starting at $124.99 and delivered by prescription nationwide. The launch follows Health Canada's approval on 28 April 2026, making Canada the first G7 country to offer generic semaglutide. Multiple generic manufacturers are now authorised to supply the Canadian market, with thousands of Canadians having registered interest through the platforms' waitlist. Dr Mark Broussenko, Medical Director at Phoenix and Raven, described the generic approval as "a turning point" for medication access in Canada. The medication is available by prescription only, with eligibility determined by licensed Canadian prescribers through the telehealth platforms.
Phoenix and Raven become first Canadian telehealth platforms to offer generic semaglutide direct to patients. Business Wire Published May 20, 2026 Article content Eligible Canadians can now access Health Canada-approved generic semaglutide directly, by prescription, starting at $124.99 Article content TORONTO - Today, Phoenix and Raven, leading Canadian digital health providers, announced the launch of generic semaglutide for direct-to-patient access in Canada, making them the first telehealth platform in the country to bring this medication to customers. Phoenix and Raven are looking to set the new pricing for optimal access with orders starting at $124.99, delivered by prescription across Canada. Article content For a long time, the conversation around semaglutide in Canada was simple: most people couldn't get it, and those who could, often couldn't afford it. That changes today. Article content The launch follows Health Canada's recent approval on April 28, 2026, making Canada the first G7 country to offer a generic semaglutide. With multiple generic manufacturers now authorized to supply the Canadian market, today's launch signals the beginning of a new era of accessibility for a medication that has fundamentally reshaped conversations about chronic disease, weight, and preventive health. Article content Top Stories Interested in more newsletters? Browse here. Article content Demand ahead of launch has been significant, with thousands of Canadians having registered interest through the platform's waitlist. The generic semaglutide offered by Phoenix and Raven is supplied and distributed domestically. Article content "For a long time, the conversation around semaglutide in Canada was simple: most people couldn't get it, and those who could, often couldn't afford it. That changes today," says Dr. Mark Broussenko, Medical Director at Phoenix and Raven. Article content "Generic approval is a turning point, not just for this medication, but for how Canadians think about access to care. When effective, evidence-based treatment becomes accessible and affordable, that's not just good for individual patients, it has the potential to meaningfully shift outcomes on a national level. This is what progress in Canadian healthcare looks like, and we are proud that Phoenix and Raven are the first digital telehealth providers to offer generic semaglutide to patients." Article content Phoenix and Raven are Canada's leading telehealth platforms providing trusted online medical care designed for both men and women's needs and lifestyle. Both platforms facilitate access to licensed Canadian physicians, treatment options, and free, discreet shipping of prescription medication from coast to coast. Semaglutide is available by prescription only, with eligibility determined by a licensed Canadian prescriber. Patients are encouraged to speak with their provider to find out if it's right for them. Visit phoenix.ca and getraven.com to learn more. Article content ABOUT PHOENIX & RAVEN Article content Phoenix is Canada's leading digital health clinic for men, specializing in three areas of treatment - erectile dysfunction, weight loss, and hair loss. Phoenix also launched Raven, a telehealth platform built to support women through every stage of their health journey, tailored to their needs, including treatments for weight loss, and hair loss. Both platforms facilitate access to licensed Canadian prescribers, treatment options, and free, discreet shipping of prescription medication from coast to coast. Visit phoenix.ca and getraven.com to learn more. Article content View source version on businesswire.com: Article content MEDIA CONTACT Article content Kayla Moyes Article content Director of Corporate Communications, Talk Shop Media Article content 250-218-9276 Article content Advertisement 1
Trulioo partners with Phoenix Digital Health to strengthen patient trust and Access to virtual care in Canada. April 14, 2026 Leading Digital Healthcare Provider Selects Trulioo Identity Verification to Reduce Fraud, Support Compliance and Accelerate Access to Care VANCOUVER, British Columbia, April 14, 2026 - Trulioo, a leading global platform for identity verification, fraud prevention and credit decisioning, today announced its partnership with Phoenix Digital Health Inc. ("Phoenix"), Canada's leading telehealth platform delivering virtual care access nationwide. Phoenix has selected Trulioo KYC Documents to verify patient identities at onboarding, reducing fraud and enabling faster access to medical services for patients across its Phoenix and Raven brands. As Phoenix continues to expand its services across Canada, it remains increasingly important to maintain patient trust and platform integrity. To further strengthen compliance with the Personal Information Protection and Electronic Documents Act (PIPEDA), Phoenix required a trusted identity verification partner with Canadian data hosting capabilities and a strong commitment to data integrity to ensure patient information remains secure and within the country. "We chose Trulioo for its ability to deliver a best-in-class patient experience without compromising safety, security or regulatory rigor." said Lucas Playford, Vice President of Product at Phoenix. "At Phoenix, becoming Canada's most trusted healthcare company starts with protecting patients from day one. This partnership enables a seamless, secure onboarding experience for people across Canada while supporting Canadian innovation, closely aligning with our commitment to building patient-centric products grounded in privacy, security and trust." Trulioo KYC Documents combines advanced document capture with automated verification technology, enabling fast, accurate identity checks that support compliance and streamline access to care. By implementing document-based identity verification, Phoenix can confidently verify patient identities while reducing manual reviews, accelerating access to care, and delivering a seamless onboarding experience. "Digital healthcare providers like Phoenix are redefining how Canadians access care, but that innovation must be built on a foundation of trust," said Vicky Bindra, Trulioo CEO. "We're proud to support Phoenix with identity verification that helps safeguard patient data, meet regulatory requirements and enable secure, seamless access to care. Together, we're setting a new standard for trusted, accessible digital healthcare in Canada." About Phoenix Digital Health Inc. Phoenix is a leader in Canada's digital health space. Its Phoenix and Raven platforms help patients access healthcare services and treatment options, with free, discreet shipping of prescription medication from coast to coast. Visit phoenix.ca and getraven.com to learn more. About Trulioo: Trulioo is an industry-leading onboarding platform, trusted by global enterprises for their identity verification, fraud prevention and credit decisioning needs. Offering business and person verification across the globe, Trulioo covers 195 countries and can verify more than 14,000 ID documents and 700 million business entities while checking against more than 6,000 watchlists. Trulioo enables global companies to prevent fraud and inform credit decisioning through hundreds of predictive risk signals, consortium data and industry-specific machine learning models. Its comprehensive suite of in-house capabilities, integrated across a single automated platform, powers customizable onboarding workflows tailored to meet any market requirement. Combining its state-of-the-art technology with deep expertise across diverse regions, Trulioo enables the highest assurance levels across verification and decisioning, optimizing onboarding costs and fostering trust in the global digital economy. Media Contacts:
Roca Group has acquired the Australian company Phoenix, which specializes in mid-to-high-end market faucets. The acquisition strengthens Roca's presence in Australia, where it already operates with its global brands Roca and Laufen. Phoenix, based in Melbourne with additional facilities in Balcatta (Perth), reported a revenue of €35 million in 2024. The financial details of the transaction were not disclosed.
Phoenix raises CAD$50M in Series C funding.
Phoenix is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Phoenix
Industries
Consumer Software
Healthcare
Company Size
51-200
Company Stage
Debt Financing
Total Funding
$37M
Headquarters
Toronto, Canada
Founded
2020
Phoenix is Hiring for 10 Jobs on Simplify!
Find jobs on Simplify and start your career today